Lakeside Behavioral Health Expands Mental Health Services in O'Fallon with New TMS Location

Lakeside Behavioral Health Expands in O'Fallon, Illinois

Lakeside Behavioral Health has exciting news for the community: on June 1, they will inaugurate their second regional facility in O'Fallon, Illinois. This new location aims to broaden access to their widely praised transcranial magnetic stimulation (TMS) therapy, that has shown significant outcomes in treating various mental health conditions, particularly major depressive disorder.

The O'Fallon facility will mirror the clinical services offered at their existing location in St. Louis, a trusted name in the field of behavioral health. The St. Louis facility has a commendable record of patient outcomes, significantly enhancing mental health care accessibility across the Metro East region.

The expansion is crucial in addressing the scarcity of specialty mental health services in the area, where the ratio of mental health providers has historically not kept pace with the population growth. Dr. Ashok Yanamadala, Medical Director at Lakeside, noted that patient outcomes have been impressive. Analysis of 224 patients treated for depression revealed that 70.1% experienced a significant clinical response, defined as a 50% or greater reduction in their depression severity on the Patient Health Questionnaire-9 (PHQ-9). Moreover, over half of the patients, specifically 50.4%, achieved clinical remission, with PHQ-9 scores falling below 5.

For individuals who presented with more severe forms of depression, an encouraging 43.9% reached clinical remission by the end of their treatment. On average, patients reported a 59.1% reduction in symptoms, a statistic that is particularly notable considering that published standards generally indicate response rates of 50-60% and remission rates of only 30-35% for TMS therapy.

Transcranial magnetic stimulation is a revolutionary approach in mental health treatment that employs non-invasive procedures to stimulate specific brain regions using magnetic fields. Originally cleared by the FDA for depression treatment in 2008, its applications have expanded to include other mental health conditions such as obsessive-compulsive disorder. The standard TMS treatment course involves daily sessions for about six weeks, making it both effective and manageable for those seeking help.

Lakeside’s commitment to transparent reporting on patient outcomes not only sets a benchmark within the community but also reinforces the credibility of TMS as a viable treatment option. They aim to bring a structured and supportive environment to O'Fallon, where patients can access these essential services.

As part of their commitment to improving mental health care quality, Lakeside Behavioral Health emphasizes accountability in measuring treatment outcomes. The new O'Fallon location stands to benefit many in the region who have struggled with untreated mental health conditions due to lack of access to specialized care.

For more extensive details on their operational methodologies and additional context regarding their outcomes, interested parties can visit their official announcement at lakesidebh.com.

Overall, Lakeside Behavioral Health’s new O'Fallon facility promises to be a milestone in advancing mental health treatment accessibility and effectiveness in the Metro East area, undoubtedly supporting the journey of many toward better mental health.